Hematopoiesis in ovarian cancer survivors to determine risk of secondary blood cancers [Video]

Elizabeth Swisher, MD, University of Washington, Seattle, WA, discusses an ongoing study (NCT06295965) investigating clonal hematopoiesis in ovarian cancer survivors to determine risk of secondary blood cancers. This interview took place at American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.